147 related articles for article (PubMed ID: 22397722)
1. CCL2 and CXCL2 enhance survival of primary chronic lymphocytic leukemia cells in vitro.
Burgess M; Cheung C; Chambers L; Ravindranath K; Minhas G; Knop L; Mollee P; McMillan NA; Gill D
Leuk Lymphoma; 2012 Oct; 53(10):1988-98. PubMed ID: 22397722
[TBL] [Abstract][Full Text] [Related]
2. Inflammatory cytokines and signaling pathways are associated with survival of primary chronic lymphocytic leukemia cells in vitro: a dominant role of CCL2.
Schulz A; Toedt G; Zenz T; Stilgenbauer S; Lichter P; Seiffert M
Haematologica; 2011 Mar; 96(3):408-16. PubMed ID: 21134984
[TBL] [Abstract][Full Text] [Related]
3. CCL2 in chronic lymphocytic leukemia: a macro in microenvironment?
Gandhi V; Balakrishnan K
Leuk Lymphoma; 2012 Oct; 53(10):1849-50. PubMed ID: 22563818
[No Abstract] [Full Text] [Related]
4. Chronic lymphocytic leukemia cells induce anti-apoptotic effects of bone marrow stroma.
Plander M; Ugocsai P; Seegers S; Orsó E; Reichle A; Schmitz G; Hofstädter F; Brockhoff G
Ann Hematol; 2011 Dec; 90(12):1381-90. PubMed ID: 21465189
[TBL] [Abstract][Full Text] [Related]
5. Targeting the IL-17/IL-6 axis can alter growth of Chronic Lymphocytic Leukemia in vivo/in vitro.
Zhu F; McCaw L; Spaner DE; Gorczynski RM
Leuk Res; 2018 Mar; 66():28-38. PubMed ID: 29353760
[TBL] [Abstract][Full Text] [Related]
6. Revisiting the role of interleukin-8 in chronic lymphocytic leukemia.
Risnik D; Podaza E; Almejún MB; Colado A; Elías EE; Bezares RF; Fernández-Grecco H; Cranco S; Sánchez-Ávalos JC; Borge M; Gamberale R; Giordano M
Sci Rep; 2017 Nov; 7(1):15714. PubMed ID: 29146966
[TBL] [Abstract][Full Text] [Related]
7. Release of interleukin-6 in cultured B-chronic lymphocytic leukaemia cells is associated with both activation and cell death via apoptosis.
Büssing A; Stein GM; Stumpf C; Schietzel M
Anticancer Res; 1999; 19(5B):3953-9. PubMed ID: 10628337
[TBL] [Abstract][Full Text] [Related]
8. Role of the RANKL/RANK system in the induction of interleukin-8 (IL-8) in B chronic lymphocytic leukemia (B-CLL) cells.
Secchiero P; Corallini F; Barbarotto E; Melloni E; di Iasio MG; Tiribelli M; Zauli G
J Cell Physiol; 2006 Apr; 207(1):158-64. PubMed ID: 16270354
[TBL] [Abstract][Full Text] [Related]
9. Induction of CXCL2 and CCL2 by pressure force requires IL-1β-MyD88 axis in osteoblasts.
Maeda A; Bandow K; Kusuyama J; Kakimoto K; Ohnishi T; Miyawaki S; Matsuguchi T
Bone; 2015 May; 74():76-82. PubMed ID: 25603464
[TBL] [Abstract][Full Text] [Related]
10. Modulation of IL-4 level by fludarabine and its relation to apoptosis in chronic B-cell lymphocytic leukemia.
Shamaa LA; Hussein Ael-S; Balbaa OA; Farahat NM; Ali MA
Egypt J Immunol; 2008; 15(1):181-92. PubMed ID: 20306682
[TBL] [Abstract][Full Text] [Related]
11. Effect of interleukins on the proliferation and survival of B cell chronic lymphocytic leukaemia cells.
Mainou-Fowler T; Copplestone JA; Prentice AG
J Clin Pathol; 1995 May; 48(5):482-7. PubMed ID: 7629299
[TBL] [Abstract][Full Text] [Related]
12. Association of interleukin-6 and interleukin-8 with poor prognosis in elderly patients with chronic lymphocytic leukemia.
Yoon JY; Lafarge S; Dawe D; Lakhi S; Kumar R; Morales C; Marshall A; Gibson SB; Johnston JB
Leuk Lymphoma; 2012 Sep; 53(9):1735-42. PubMed ID: 22475215
[TBL] [Abstract][Full Text] [Related]
13. Differential binding of chemokines CXCL1, CXCL2 and CCL2 to mouse glomerular endothelial cells reveals specificity for distinct heparan sulfate domains.
van Gemst JJ; Kouwenberg M; Rops ALWMM; van Kuppevelt TH; Berden JH; Rabelink TJ; Loeven MA; van der Vlag J
PLoS One; 2018; 13(9):e0201560. PubMed ID: 30248108
[TBL] [Abstract][Full Text] [Related]
14. A combination of cytokines rescues highly purified leukemic CLL B-cells from spontaneous apoptosis in vitro.
Ghamlouch H; Ouled-Haddou H; Damaj G; Royer B; Gubler B; Marolleau JP
PLoS One; 2013; 8(3):e60370. PubMed ID: 23555960
[TBL] [Abstract][Full Text] [Related]
15. In contrast to high CD49d, low CXCR4 expression indicates the dependency of chronic lymphocytic leukemia (CLL) cells on the microenvironment.
Kriston C; Plander M; Márk Á; Sebestyén A; Bugyik E; Matolcsy A; Barna G
Ann Hematol; 2018 Nov; 97(11):2145-2152. PubMed ID: 29955944
[TBL] [Abstract][Full Text] [Related]
16. Adhesion of ZAP-70+ chronic lymphocytic leukemia cells to stromal cells is enhanced by cytokines and blocked by inhibitors of the PI3-kinase pathway.
Lafarge ST; Johnston JB; Gibson SB; Marshall AJ
Leuk Res; 2014 Jan; 38(1):109-15. PubMed ID: 23981382
[TBL] [Abstract][Full Text] [Related]
17. CCL3 as Possible Negative Prognostic Factor in Chronic Lymphocytic Leukemia.
Popek-Marciniec S; Zmorzyński S; Koczkodaj D; Marciniec M; Wąsik-Szczepanek E; Karczmarczyk A; Michalak-Wojnowska M; Filip A
Acta Haematol; 2023; 146(4):277-286. PubMed ID: 37015191
[TBL] [Abstract][Full Text] [Related]
18. Cathepsin C aggravates neuroinflammation via promoting production of CCL2 and CXCL2 in glial cells and neurons in a cryogenic brain lesion.
Zhao X; Liu S; Yang X; Liu Y; Liu G; Fan K; Ma J
Neurochem Int; 2021 Sep; 148():105107. PubMed ID: 34171415
[TBL] [Abstract][Full Text] [Related]
19. Interleukin-6 inhibits apoptosis and tumour necrosis factor induced proliferation of B-chronic lymphocytic leukaemia.
Reittie JE; Yong KL; Panayiotidis P; Hoffbrand AV
Leuk Lymphoma; 1996 Jun; 22(1-2):83-90, follow. 186, color plate VI. PubMed ID: 8724532
[TBL] [Abstract][Full Text] [Related]
20. The STAT3 inhibitor WP1066 reverses the resistance of chronic lymphocytic leukemia cells to histone deacetylase inhibitors induced by interleukin-6.
Lu K; Fang XS; Feng LL; Jiang YJ; Zhou XX; Liu X; Li PP; Chen N; Ding M; Wang N; Zhang J; Wang X
Cancer Lett; 2015 Apr; 359(2):250-8. PubMed ID: 25636517
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
